Century-old drug as potential new approach to autism
Friday, May 26, 2017 - 14:51
in Psychology & Sociology
In a small, randomized Phase I/II clinical trial (SAT1), researchers say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.